Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study

CompletedOBSERVATIONAL

Enrollment

82,903

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

October 31, 2010

Conditions

Asthma

Interventions

DRUG

extra-fine hydrofluoroalkane beclometasone dipropionate

DRUG

Fluticasone propionate

Trial Locations (1)

Research in Real Life, Cawston

All Listed Sponsors

collaborator

i3 Research

INDUSTRY

collaborator

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

lead

Research in Real-Life Ltd

NETWORK

NCT01287351 - Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study | Biotech Hunter | Biotech Hunter